BRIM BIOTECHNOLOGY INC has a total of 29 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are KHANNA PUSHPA, LEVETAN CLARESA and CHEER GLOBAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Taiwan | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Republic of Korea | 4 | |
#6 | Israel | 3 | |
#7 | China | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Tsao Yeou-Ping | 19 |
#2 | Ho Tsung-Chuan | 19 |
#3 | Lee Frank Wen-Chi | 19 |
#4 | Lee Yuan-Ming | 8 |
#5 | Lin Kuanyin Karen | 5 |
#6 | Tsao Yeou Ping | 4 |
#7 | Lee Frank Wen Chi | 4 |
#8 | Fan Nai-Wen | 4 |
#9 | Ho Tsung Chuan | 4 |
#10 | Huang Ping-Yen | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021077125A2 | Compositions comprising pedf-derived short peptides (pdsp) and uses thereof | |
WO2020033929A1 | Method for suppression of hepapitis b virus replication and hepapitis b virus surface antigen secretion | |
AU2019262664A1 | PEDF-derived peptides for promoting meibomian gland regeneration and uses thereof | |
KR20200140843A | Application of PEDF-derived short peptides to the treatment of osteoarthritis | |
EP3761959A1 | Application of pedf-derived short peptides in tendon healing | |
KR20190066030A | Compositions comprising PEDF-derived short peptides and uses thereof |